Cotización Lifevantage - LFVN

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

15.28

Postura de Compra

15.28

Postura de Venta

16.83

Volume Operado de la Acción

0.00 Rango del Día 0.00

5.22 Rango de 52 semanas 15.8814

Capitalización de Mercado [m]

191.385M

Precio Anterior

15.28

Precio de Apertura

Hora

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

97,124

Acciones en circulación

12,525,229

Rendimiento del Dividendo

1.05%

Ratio Precio/Utilidad

65.16

Beneficio por acción (BPA)

0.23

turnover

200.16M

Beneficio neto

2.94M

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio en... Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Finance Services

Sitio web

www.lifevantage.com/us-en

Sede

Wilmington, Delaware, USA

Fundado

2005

Lifevantage Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LFVN. The last closing price for Lifevantage was US$15.28. Over the last year, Lifevantage shares have traded in a share price range of US$ 5.22 to US$ 15.8814.

Lifevantage currently has 12,525,229 shares in issue. The market capitalisation of Lifevantage is US$191.39 million. Lifevantage has a price to earnings ratio (PE ratio) of 65.16.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	1.53	11.1272727273	13.75	15.8814	13.65	80188	14.77226635	CS
4	1.48	10.7246376812	13.8	15.8814	12.8	83534	13.98520823	CS
12	6.03	65.1891891892	9.25	15.8814	8.94	97124	12.60534041	CS
26	7.67	100.788436268	7.61	15.8814	5.22	81722	10.44071612	CS
52	8.96	141.772151899	6.32	15.8814	5.22	59694	9.24956398	CS
156	8.86	138.00623053	6.42	15.8814	3.04	48252	6.9053558	CS
260	0.32	2.13903743316	14.96	17.25	3.04	64662	9.03076033	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CTNTCheetah Net Supply Chain Service Inc	US$ 4.64 (148.13%)	9.37M
JANXJanux Therapeutics Inc	US$ 65.76 (63.66%)	12.48k
CTORCitius Oncology Inc	US$ 1.65 (61.76%)	8.19M
CRDOCredo Technology Group Holding Ltd	US$ 67.00 (40.17%)	85.55k
SHIMShimmick Corporation	US$ 3.65 (30.36%)	1.64M
DMRCDigimarc Corporation	US$ 26.00 (-24.57%)	109
AXGNAxogen Inc	US$ 11.01 (-24.38%)	1
GELSGelteq Ltd	US$ 2.92 (-23.57%)	6.06k
TBRGTruBridge Inc	US$ 14.00 (-22.65%)	4
BWMNBowman Consulting Group Ltd	US$ 21.00 (-21.20%)	115
CTNTCheetah Net Supply Chain Service Inc	US$ 4.64 (148.13%)	9.37M
CTORCitius Oncology Inc	US$ 1.65 (61.76%)	8.19M
UOKAMDJM Ltd	0.2891 (0.00%)	4.86M
KITTNauticus Robotics Inc	US$ 1.32 (17.86%)	2.29M
SMCISuper Micro Computer Inc	US$ 44.92 (6.95%)	2.06M